Companies · Other Health Care

HGI Global Holdings, Inc.

Twinsburg · Other Health Care

Diligence memoA one-page analyst read on HGI Global Holdings, Inc. — recommendation, valuation, rhythm, risks.
$10.2M
Total raised · real
2
Rounds
1.0×
Latest step-up
Top 25%
Sector rank · raised
Series A
Latest stage · inferred · Fri Oct 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

HGI Global Holdings, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.99× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
  • Within the normal band (99% of peer median) for its niche.
Dormant
  • Last raise 15.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

HGI Global Holdings, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
15.8 yr record
Peak capital year was 2010 with $21.6M across 4 filings.
Market position
ahead of 76% of Other Health Care peers
Capital scale is ahead of 76% of Other Health Care peers; modeled value is above 81% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2010: $21.6M across 4 filings.
  • Largest single filing was $5.7M on 2010-10-01.
  • Filing rows sum to $21.6M, while canonical raised total is $10.2M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

HGI Global Holdings, Inc. is one of 5377 Other Health Care companies tracked from Twinsburg. By capital raised it ranks in the upper tier (ahead of 76% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2010-10-01 Raised $5.7M (real) Modeled valuation $115M (est)$5.7M$115MSeries A2010Series A · 2010-10-01 Raised $4.5M (real) Modeled valuation $91M (est)$4.5M$91MSeries A2010Series A · 2010-10-01 Raised $5.7M (real) Modeled valuation $115M (est)$5.7M$115MSeries A2010Series A · 2010-10-01 Raised $5.7M (real) Modeled valuation $115M (est)$5.7M$115MSeries A2010+$4.5M+$5.7M+$5.7MCumulative $22M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.7M · 2010
Series A extension$4.5M · 2010
Series A extension$5.7M · 2010
Series A extension$5.7M · 2010

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$115.0M
Base estimate est.
$7.3M
Conservative case
$625.4M
Upside case
$25.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $115.0M · 2010-10-012010Series A · modeled $90.8M · 2010-10-01Series A · modeled $115.0M · 2010-10-01Series A · modeled $115.0M · 2010-10-012010
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
15.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
15.8 yr
On record since
2010
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.2× above median
This company$10.2M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.0× above median
This company$5.7M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 5.2× above median
This company$115.0M
Sector median$22.1M

Raised more than 76% of sector peers (real $). Modeled value above 81% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #101 of 199.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)HGI Global Holdings, Inc. (this company) Raised $10.2M · modeled $115.0M (est)HGI Global Holdings, Inc.
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
HGI Global Holdings, Inc. this companySeries A$10.2M$115.0M0.99×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.7M2010-10-01$25.9M$115.0M90%
Series A$4.5M2010-10-01$20.5M$90.8M90%
Series A$5.7M2010-10-01$25.9M$115.0M90%
Series A$5.7M2010-10-01$25.9M$115.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.7M2010-10-01
    • First recorded raise — entered as Series A.
  2. Series A$4.5M2010-10-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Series A$5.7M2010-10-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Series A$5.7M2010-10-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
Intelligence
Modeled next raise
$5.7M
Modeled next size est.range $5.7M$9.1M
1.0×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Theresa A. Gore14 other2010-10
Thomas J. Carella3 other2010-10
Jack L. Wyszomierski1 other2010-10
Paul A. Pressler1 other2010-10
Andrew A. Rhee2010-10
Andrew B. Rhee2010-10
Christopher Lindroth2010-10
Derek A. Strum2010-10
George A. Jaquette2010-10
George Jaquette2010-10
Joseph A. Gleberman2010-10
Joseph B. Gleberman2010-10
Kurt Packer2010-10
Michael B. Petras2010-10
Paul B. Pressler2010-10
Richard A. Schnall2010-10
Richard B. Schnall2010-10
Steven L. Eisenberg2010-10
Registry & provenance

HGI Global Holdings, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1503201
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
CDRH Topco, Inc.Other Health CareSeries A$6.0M$120.9Mnetwork1 shared operator · same sector · same stage
ITA Partners, Inc.Other Health CareSeries A$10.1M$102.7Msame sector · same stage
Bovie Medical CorpOther Health CareSeries A$10.0M$141.3Msame sector · same stage
Eyevensys S.A.S.Other Health CareSeries A$10.0M$136.8Msame sector · same stage
Excelimmune, IncOther Health CareSeries A$10.5M$121.1Msame sector · same stage
Dorsata, Inc.Other Health CareSeries A$9.9M$105.7Msame sector · same stage
Innovoyce LLCOther Health CareSeries A$9.9M$97.6Msame sector · same stage
GT Urological LLCOther Health CareSeries A$10.6M$100.9Msame sector · same stage
Frequently asked
How much funding has HGI Global Holdings, Inc. raised?
HGI Global Holdings, Inc. has raised approximately $10.2M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is HGI Global Holdings, Inc.'s estimated valuation?
Provath's modeled valuation for HGI Global Holdings, Inc. is approximately $115.0M (modeled range $7.3M–$625.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is HGI Global Holdings, Inc. at?
HGI Global Holdings, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Oct 01.
What does HGI Global Holdings, Inc. do and where is it based?
HGI Global Holdings, Inc. operates in the Other Health Care sector, based in Twinsburg.
Explore related

See where HGI Global Holdings, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at HGI Global Holdings, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.